Imaging studies are often obtained du ring the evaluation ofthe pat ient with an olfactory defi cit. The purp ose ofthis article is to describe an investigation that was conducted to assess the effec tiveness ofimaging studies in determining the etiology of olfac tory loss in the patient with an isolated complaint ofanosmia and no relevantfin dings on physical examination. including nasal endoscopy. The author conducted a retrospective review of the records of 20 women and eight men, aged 22 to 71years (mea n: 45), whose durati on ofanosmia had rangedfrom I month to 2 years (median: 3 tno). Twenty of these pati ents had undergone cont rast-enhanced magnetic resonan ce imaging of the paranasal sinuses and brain. and the other eight had undergone enhanced computed tomography. The authorfound that these imaging studies did not add to the inf ormati on obtained by the clinical history and endoscopic nasal examination and were thus not useful in determining the cause of anosmia. Based on these fi ndings, the auth or does not recomm end that imaging studies be included as part of the evaluation of these pati ents.
Introduction
Th e true incidence of anos mia is difficult to determ ine, although the National Institutes of Health have estim ated that more than 2 mill ion persons in the United States have a smell dysfunction.I The etiology of olfactory loss is varied. Based on the site of the path ology, cl inical olfactory deficits are clas sifie d as one of three types: transport, From sensory , or neural? Transport olfac tory losses are caused by lesions that block the airflow to the olfac tory reg ion of the nose. Senso ry disorders are the result of a dire ct inju ry or damage to the olfac tory neuroepithelium. Neural deficit s are attrib utable to disease processes that affec t the olfactory bulb , olfac tory trac t, or the cen tral olfactory path way, incl uding the prefront al lob e, septal nucl ei, amygdala, and temporal lobe. Th e most co mmon cause of olfact ory dysfun ction is sinonasal dise ase.' Ot her reported co ntributing factors include postvira l upper respiratory tract infection (URI), head traum a, agin g, co nge nital anomalies, ex pos ure to toxic substances, medication side effec ts, neurologic disorders, sinonasa l tum ors, and intracrania l tumors. In some patients, the etiology remains unknown despit e extensive evaluation.'
A detailed clinical history and physical exa mination, including nasal endoscopy, is esse ntial to a prope r eva luation. In many cases, imagin g studies of the brain and par ana sal sinuses are obtained in an effort to dete rmine the site and nature of the und erlying path ology . Th e most co mmon of these studies are high-resoluti on magnetic reso nance imaging (MRI) and co mputed to mograp hy (CT) .
Th e purp ose of the investigation described in this article was to determ ine the yield of imagi ng studies in help ing to ident ify the etiology of the olfac tory disorder in pati ent s who had an iso lated complaint of anos mia and in who m the endos copic nasal examination was unremarkable.
Patients and methods
Th e author co nducted a retro spec tive re view of all patie nts who had co me to his office with a chief co mplaint of anosmia duri ng a 5-year period. Incl usion crite ria for this study incl uded an isolated co mp laint of acq uired anosmi a and an unr em ar kable nasal exa minatio n (anterior rhinoscopy and nasal endosco py ). Th e diagnosis of anosmia was based solely on each pat ien t' s co mplaint and was not verifi ed or investigated furt her by specific olfac- 
Results
The du ration of anos m ia sym pto ms amo ng the 28 patients ranged from 1 mo nth to 2 years (median: 3 mo) (ta ble I). Twenty-two patient s sai d that the onse t of their sympto ms had been sudden, while the other six reported a gra dual loss of smell over a period of2 to 4 weeks . No pa tie nt had co mplai ned of nasal obstruction or dr ainage. Twenty-one pat ients reported that they had ex per ienced a URI prior to the onse t of their anosmia. T hree patients had a history of env iro nmental allergy that was adequately co ntro lled wi th oral antihis tamines.
Nasal examinatio n (anterior rhin oscopy and nasal endoscop y) had revealed a deviatio n of the nasal septum in five patient s and inferior turbi nate hypert rophy in four. Phys ica l examina tio n showed that the nasal airway in these nine pa tients had been narrowed by less than 25 % in tor y function testing. Patient s who had a history of rhi nosin usitis, sinonasal or sk ull base surgery, epistaxis, visual or oc ular co mp lai nts, hea dac he, or a know n neu rol ogic disorder were excluded from thi s st udy . Also excluded were patient s who we re noted on physical examination and nasal endoscopy to have had intranasal po lyps , a tumo r, or any findi ngs consistent wit h rhinosinu sitis.
T went y-eight patien ts-20 women and eigh t me n, aged 22 to 7 1 yea rs (mean: 45)-met the clinical criteria for incl usio n. Th eir medical records we re reviewed for demographic da ta as we ll as for info rma tion on the duration of sympto ms, any history of antecedent URI , find ings on physical exami nation, and the nat ure and duration of med ical treatmen t.
All patients in this ser ies had undergone an imaging eval uation by eit her MRI or CT. T he res ults of the imagi ng studies reported in thi s article are based on the interpretations of the radio logists who read them.
Findings on nasal examinatio n:
Deviated septu m Inferior turb inate hypertroph y 5 patie nts 4 patients three pa tie nts, between 25 and 50 % in five, and more than 50 % in one. In no case was the narrowing j udge d to be severe eno ugh to block airflow to the olfac tory reg ion. Among the remai ning 19 patien ts, findi ngs on nasal examinatio n were unremarkable. All patients had been started on a tapering short co urse of an oral corticosteroid (usually meth ylp rednisolone) and a I-mon th co urse of a stero id nasal spray . Those who experienced eithe r a par tial or complete recovery of sme ll function were co ntinued on the nasal spray for 2 additional months.
T went y patients had undergone contras t-enhanced M RI of the brai n and paranasal sinuses as part of their evaluation. A maxillary retentio n cys t was de tec ted in three of these patients, mild mucosal thickening in the maxi llary and ethmo id sinuses in two, a nasop alat ine cys t in one , and a dee p-lobe parotid tumor in one (ta ble 2) . Findi ngs on the re ma ining 13 MR I studies were norm al.
En hanced CT had bee n performe d on eight patients. CT detected a max illary sin us re tention cys t in one patient and mild mucosal thickening invol ving the ma xillary sinuses in anot her (table 2) . Findi ngs on the rema ining six CT sca ns were normal.
T he nasopalati ne cys t and the paro tid gland tum or di scovered by MRI were not associated with the olfac tory deficit in these two patients. T he de tection of a maxi llary sinus retention cys t in four patients was co nsidered to be an inciden tal finding that did not co ntri bute to the anos mia. Similarly, the "mucosal thickening see n in the max illary and ethmoid sin uses of three pati ents was mild ; the os tio meatal complex was patent in all three of these patients, and no ne ex hibited any air-t1uid leve l in the paranasal sinuses . Th ese three patie nts did not repo rt any sinonasal symptoms other than anosmia, and their nasal examination did not reveal mucosal int1 ammation or muco purulent dra inage . As a result , they were not diagnose d with sin usi tis and they were not treated with antibiotics .
Th e atta inment of imagin g studies did not alter the Volume 80, Number 12 50 to a pack, individually wr apped, ste rile and read y for use.
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Discussion
There is no site-of-lesion testing similarto audito ry evoked poten tials ava ilable to help assess olfac tory disord ers. Electrop hysio log ic tests such as olfactory evoked potentials and electro-olfactography are pri ma rily co nfined to research efforts and are generally not ava ilable in the patient care setting. Con sequentl y, e fforts to determine the natu re of the underl ying pathology are based pri mar ily on the cl inical ev aluation. T his entails a detailed medical history, physic al examinatio n (including the neuro logic sys tem), and nasal endo sco py. Imaging studies are ge nerall y obta ined when an anatomic deform ity or obstruc tion is suspec ted, when there is a history of nasal or sinus disease, or when the diagn osis is not clea r. Th e most frequently utilized imag ing studies are M RI and CT .5.6 Functio nal MRI has been used for precise locali zation of olfactory processing , and might allow for more acc urat e diagnoses of olfac tory disorders in the future.' Nasa l infla mmato ry di sea ses such as rhin osinusit is, rhinitis, and nasal po lyposis are the most co mmon and most treatable types of olfactory dysfun ct ion ." Sinonasal disea se ca uses olfac tory loss main ly by limiting the airflow to the olfactory regi on ." Such pati ents typ ica lly complain of nasal conge stion or obstruc tio n. Ant erior rhin oscop y and nasal endoscopy can assess the degree of obstruction of the nasal airway . A recent study by Kern identi fied infl ammatory changes in the o lfac tory mucosa of patients with rhin osinu sit is that can be respo nsible, at least in part, for an olfactory deficit." However, the author is not awa re of any rep ort in the Engli sh-language literature in whic h an osmi a was the o nly sy m pto m o f rhinosinusitis.
Intranasal masses such as polyp s or neoplasms can ca use anosmia either by inter fering with the patency of the nasal airway or by d irec tly destroyi ng the olfactory receptors. Soft -tis sue masses of th is size present with nasal obstruction or epis tax is, with anos mia being a late sy mptom .!" Such masses are rea dily visua lized with nasal endoscop y.
Nu merous ce ntral nervous system disord ers are assoc iated with olfactory dysfun ction. They includ e Alzheimer' s disease,I I Parkin son ' s disease," Hu ntington' s disease, Korsakoff' s psych osis, schizophrenia, co ngenital anosmia (most co mmonly Kallmann' s syndrome), head trauma, and brain tumor.' T he multipla nar capab ility of MRI is especially adva ntag eous in the evaluation of brain disorders.
Patien ts with Al zheimer ' s disease have been shown to medical treatmen t of any of the patients in this series . The etio logy of the ano smia was de term ined to be post viral (pos t-URI) in 2 I patient s and idiopath ic in se ven. Five of the patient s with post vir al anos mia and one with idiopathic anosm ia subsequently rep orted th at they had experien ced either a partial or full recover y of thei r sense of smell.
" the easy way! (tip can't come om) have a significantly poorer average olfac tory threshold sensi tiv ity than do age-matched controls. I I Th is ph en omenon is believed to be ne uro logically mediated. On brain imaging , the anterior olfactory nuclei, olfacto ry bu lbs, amygdala, and temporal lob es in Alzheimer's pa tients ex hibi t se nile plaques, ne urofibr illary tangles, gra nulovasc ular degeneration, and cell loss,'
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NO MORE MESS !
Patient s with Parkinson ' s disease experience a ge neralized imp airment of olfac tory identi fication that does not correlate wit h disease du ration , motor functio n, tremor, or cog nition." Th e maj or fea ture of Parkinson ' s disease on MRI appears to be a trend toward a narrowing of the pars co mpacta of the substan tia nigra. Positron-emi ssion tomograp hy and single-photon-emission tomography can reve al a moderate global decrease in cere bra l metab oli sm , espec ially in the tem porop arietal region .'
Th e prevalence of chemosensory changes ca use d by intracrania l tumo rs has rare ly been investigated. In a study of 750 co nsec utive patients wit h chemosensory diso rders see n at the University of Penn sylvan ia ' s Sm ell and Tas te Ce nter, only two cases (0.3%) were induced by bra in tumors." In general, tum ors that invo lve the o lfactory bul b, olfac tory tract , or prefront al lobe ca n ca use ol factory deficits, while temporal lobe tumors are assoc iated with olfac tory halluci nation. However, patients wit h tum ors us ually have vis ual co mplaints or other tell ing ce ntra l ner vou s sys tem sig ns and symptoms . In a series of 36 patients with olfac tory men ingiom as, Bakay found that 83% had visual deficits.14 In additio n, 70% of these patie nts had ment al cha nge s such as dementi a, disorientation , speech disord ers, and urinary and feca l incontinence.
In the present series, the author excl uded patients who had a know n neurol ogic di sorder and those who co mplained of visua l changes or other neu rol ogic sy mpto ms . T he brain imaging scan s of those who were studied did not produ ce any findings that wo uld elucidate the etiology of anosmia in any of the 28 patien ts. Furtherm ore, these imag ing studies did not detect any sinonasal path ology relevan t to anos mia that was missed by the medical histor y an d nasal exa mination, includi ng nasal endoscopy. Co ns ideri ng the cos t and potent ial morbidity of me dical imaging, the author believes that sinonasal and brai n imaging is not indica ted in the evaluatio n of patient s who have an isolated co mplaint of anos mia without other neu rolo g ic signs and sy mptoms and in who m the nasal examination, including nasal endoscopy , is unr em arkable. However, this recommend ation ca nnot be ex tra polated to enco mpass all patient s with olfactory deficits, because the present series is sma ll. Larger studies are needed to better address this issue.
Th e role of objective olfac tory testin g in the diag nosis and treatm en t of olfac tory disor ders is co ntrove rsial. Th e diagnosis of anos mia in this study was base d on the med ical history, without objective olfac tory functio n test- T Medica l TechnOl og . . ; . i e . . ; S : . . . . C -orpo --r a-t~i o-n----------BUSABA ing. However , the author believes that his findings and recomm en dation s wou ld not have bee n any differen t had the olfactory loss been on ly par tial. In order for sinonasa l disease or central ner vous system disorders (includ ing tumors) to cause a complete loss of olfaction, the pathology would have had to be more ad vanced than that which ca use s a parti al loss. Instead of having anos mia alone, patie nts wit h these condi tions are likely to ex hibit sig ns or symptoms of their disease other than an olfactory co mplain t. In concl usion, imaging studies in this inve stigati on did not add any information to that available from the clinical history and endoscopic nasa l examination with respect to de ter mining the cause of anos mia. Th ere fore, the author does not reco mme nd imagi ng studies as part of the eva luation of the patien t who has an isolated complaint of anosmia and in whom the endosco pic nasal examination is unre markable. 
